ADVANTAGES OF PATIENT-SPECIFIC PREDICTIONS OVER SUBGROUP ANALYSIS IN DEFINING DIFFERENTIAL TREATMENT EFFECTS OF TPA AND STREPTOKINASE FROM THE GUSTO TRIAL
Rm. Califf et al., ADVANTAGES OF PATIENT-SPECIFIC PREDICTIONS OVER SUBGROUP ANALYSIS IN DEFINING DIFFERENTIAL TREATMENT EFFECTS OF TPA AND STREPTOKINASE FROM THE GUSTO TRIAL, Journal of the American College of Cardiology, 1994, pp. 10000027-10000027